← brief for 2026-08-14 · Slowing decline

Effects of SGLT2 inhibitors on body composition and potential sarcopenia-related outcomes in type 2 diabetes mellitus: a network meta-analysis.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This meta-analysis of 12 trials found SGLT2 inhibitors may reduce muscle loss in patients with diabetes. Results vary across studies, so it's not a clear-cut benefit.

Who did this work

Li X · Zhang Y · Wang L · Zhao Y

Source

Article · PubMed, the drug frontier · 2026 Jul 29
https://pubmed.ncbi.nlm.nih.gov/42591093/